Anti-cancer Effect of Hematopoietic Stem Cell-derived Allogeneic-DC Vaccine in Melanoma Metastasis Model
![]() |
Kim, Myoung-Joo
(The Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine)
Shon, Hye-Jin (The Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine) Baek, So-Young (The Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lee, Kang-Eun (The Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine) Lee, Young-Joon (Medipost Biomedical Research Institute) Lee, Hyun-Ah (The Cancer Center, Samsung Medical Center, Sungkyunkwan University School of Medicine) |
1 | Lee YJ, Kim MJ, IN SH, Choi OM, Baek S, Kwon YD, Lee H: Effect of dendritic cell based cancer vaccine using allogeneic tumor cell lysate in melanoma pulmonary metastasis model. Immune Network 5;163-171, 2005 과학기술학회마을 DOI |
2 | Lee H, Choi KM, Baek S, Lee HG, Jung CW: Dendritic cell based cancer immunotherapy: in vivo study with mouse renal cell carcinoma model. Immune Network 4;44-52, 2004 DOI |
3 |
Li-Cheng Xu RL, Tang Y, Ogburn PL Malinowski K, Malhjewicz S, Santiago-Schwarz F, Fan Q: Implication of delayed TNF-alpha exposure on dendritic cell maturation and expansion from cryopreserved cord blood CD3 |
4 | Guanghua G, Suzuan C, Juan Z, Lili I., Jing Y, Hongmei D, Hong X, Zhongjing S, Libiao W: Antitumor activity of a fusion of esophageal carcinoma cells with dendritic cells derived from cord blood. Vaccine 23;5225-5230, 2005 DOI ScienceOn |
5 |
Yoon HL Singh K, Ratner S, Reiners JJ: Phorbol ester effects on splenic lymphocyte composition and cytotoxic T cell activities of SSIN mice: a strain deficient in CD |
6 | Pulendran B, Maraskovsky E, Banchereau J, Malaliszewski C: Modulating the immune response with dendritic cells and their growth factors. Trends Immunol 22;41-47, 2001 DOI ScienceOn |
7 |
Martin P, Martinez del Hoyo G, Anjuere F, Ruiz SR, Arias CF, Marin AR, Ardavin C: Concept of lymphoid versus myeloid dendritic cell lineages revisited: both CD8 |
8 | O'Garra A, Vieira P: Regulatory T cells and mechanisms of immune system control. Nat Med 10;801-805, 2004 DOI ScienceOn |
9 | Kalinski P, Giermasz A, Nakamura Y, Basse P, Storkus WJ, Kirkwood JM, Mailliard RB: Helper role of NK cells during the induction of anticancer responses by dendritic cells. Mol Immunol 42;535-539, 2005 DOI ScienceOn |
10 | Marten A, Renoth S, Heinicke T, Alebers P, Pauli A, Mey U, Caspari R, Flieger D, Hanfland P, Ruecker A V, EisHubinger AM, Muller S, Schwaner I, Lohmann U, Heymann G, Sauerbruch T, Scgmidt-Wolf IGH: Allogeneic dendritic cells fused with tumor cells: preclinical results and outcome of a clinical phase I/ll trial in patients with metastatic renal cell carcinoma. Hum Gene Ther 14;483-494, 2003 DOI ScienceOn |
11 | Figdor CG, De Vires IJM, Lesterhuis WJ, Melief CJM: Dendritic cell immunotherapy: mapping the way. Leuk Lymphoma 10;475-480, 2004 |
12 | Parmiani G, Castelli C, Rivoltini L, Casati C, Tully GA, Novellino L, Patuzzo A, Tosi D, Santinami M: Immnotherapy of melanoma. Sernin Cancer Biol 13;391-400, 2003 DOI ScienceOn |
13 |
Moser M, Murphy KM: Dendritic cell regulation of T |
14 | Van den Broeke LT, Daschbach E, Thomas EK, Andringa G, Berzofsky JA: Dendritic cell-induced activation of adaptive and innate antitumor immunity. J Immunol 171;5842-5852, 2003 DOI |
15 |
Curti A, Isioiri A, Ferri E, Terragna C, Neyroz P, Cellini C, Ratta M, Baccarani M, Lemoli Rvl: Generation of dendritic cells from positively selected CD1 |
16 |
Encabo A, Solves P, Mateu E, Sepulveda P, Carbonell-Uberos F, Minana MD: Selective generation of different dendritic cell precursors from CD3 |
17 | Lee SJ, Kim MJ, In SH, Baek S, Lee H: Immunocell therapy for lung cancer: dendritic cell based adjuvant therapy in mouse lung cancer model. Immune Network 5;36-44, 2005 과학기술학회마을 DOI |
18 | Osada T, Clay T, Hobeika A, Lyerly HK, Morse MA: NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity. Cancer Immunol Immunother 55; 1122-1131, 2006 DOI |
19 | Mailliard RB, Son YI, Redlinger R, Coates PT, Giermasz A, Penelope AM, Storkus WJ, Kalinski P: Dendritic cells mediate NK cell help for Th1 and CTL responses: two-signal requirement for the induction of NK cell helper function. J Immunol 171;2366-2373, 2003 DOI |
20 | Dilioglou S, Cruse JM, Lewis RE: Function of CD80 and CD86 on monocyte- and stem cell-derived dendritic cells. Exp Mol Pathol 75;217-227, 2003 DOI ScienceOn |
21 | Wagner JE, Barker JN, Defor TE, Baker KC, Blazer BR, Eide C, Goldman A, Kersey J, Krivit W, MacMillan ML, Orchard PJ, Peters C, Weisdorf DJ, Ramsay NKC, Davies SM: Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. Blood 100;1611-1618, 2002 |
22 | Nencioni A, Brossart P: Cellular immunotherapy with dendritic cells in cancer: current status. Stem Cells 22;501-513, 2004 DOI ScienceOn |
23 | Holtl L, Zeller-Rieser C, Gander H, Papesh C, Ramoner R, Bartsch G, Rogatsch H, Barsoum AL Coggin JH Jr, Thurnher M: Immunotherapy of metastatic renal cell carcinoma with tumor lysate-pulsed autologous dendritic cells. Clin Cancer Res 8;3369-3376, 2002 |
24 |
Dietz AB, Padley DJ, Butler GW, Maas ML, Greiner CW, Gastineau DA, Pavolovic SV: Clinical-grade manufacturing of DC from CD1 |
25 | Mohty M, Olive D, Gaugler B: Leukemic dendritic cells: Potential for therapy and insights towards immune escape by leukemic blasts. Leukemia 16;2197-2204, 2002 DOI ScienceOn |
26 |
Ward KA, Stewart LA, Schwarer AP: CD34 |
27 | O'Rourke MGE, Johnson M, Lanagan C, See J, Yang J, Bell JR, Slater GJ, Kerr BM, Crowe B, Purdie DM, Elliott SL, Ellem KAO, Schmidt CW: Durable complete clinical responses in a phase I/II trial using an autologous melanoma cell/ dendritic cell vaccine. Cancer Immunol Immunother 52;387-395, 2003 |
28 | Iwashita Y, Tahara K, Goto S, Sasaki A, Kai S, Seike M, Cehn CL, Kawano K, Kitano S: A phase I study of autologous dendritic cell-based immunotherapy for patients with unresectable primary liver cancer. Cancer Immunol Immunother 52;155-161, 2003 |
29 | Hus I, Rolinski J, Tabarkiewicz J, Wojas K, Bojarska-Junak A, Greiner J, Giannopoulos K, Dmoszynska A, Schmitt M: Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia. Leukemia 19;1621-1627, 2005 DOI ScienceOn |
30 | Schuler-Thurner B, Schultz ES, Berger TG, Weinlich G, Ebner S, Toerl P, Bender A, Feuerstein B, Fritsch PO, Romani N, Schuler G: Rapid induction of tumor-specific type 1 T helper cells in metastatic melanoma patients by vaccination with mature, cryopreserved, peptide-loaded monocyte-derived dendritic cells. J Exp Med 195;1279-1288, 2002 DOI |
31 | Guardino AE, Rajapaksa R, Ong KH, Sheehan K, Levy R: Production of myeloid dendritic cells (DC) pulsed with tumorspecific idiotype protein for vaccination of patients with multiple myeloma. Cytotherapy 8;277-289, 2006 DOI ScienceOn |
32 |
Ratzinger G, Baggers J, de Cos MA, Yuan J, Dao T, Reagan JL, Munz C, Heller G, Young JW: Mature human langerhans cells derived from CD3 |
33 | Gerosa F, Gobbi A, Zorzi P, Burg S, Briere F, Carra G, Trinchicri G: The reciprocal interaction of NK cells with plasmacytoid or myeloid dendritic cells profoundly affects innate resistance functions. J Immunol 174;727-734, 2005 DOI |
34 | Hsu FJ, Benike C, Fagnoni F, Liles TM, Czerwinski D, Taicli B: Vaccination of patients with B-cell lymphoma using autol ogous antigen-pulsed dendritic cells. Nat Med 2;52-58, 1996 DOI ScienceOn |
![]() |